Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hyperimmune Globulins Market 2018, Forecast to 2023

August 2018 | 136 pages | ID: GFBCC02D124EN
GlobalInfoResearch

Abstracts

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides 'passive' immunity to the patient against an agent. This is in contrast to vaccines that provide 'active' immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant 'passive' short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

SCOPE OF THE REPORT:

This report focuses on the Hyperimmune Globulins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, global market of Hyperimmune Globulins developed rapidly, with an average growth rate of 6%. In 2017, global revenue of Hyperimmune Globulins is nearly 1150 million USD; the actual production is about 40 million units.
The classification includes the Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins and others, and the proportion of Rabies Immunoglobulins in 2017 is about 44.2%, with the largest market share.
Hyperimmune Globulins is widely used in Government Institutions, Private Sector and Other. The most proportion of Hyperimmune Globulins is sold in Government Institutions, and the proportion in 2017 is about 62.7%.

The worldwide market for Hyperimmune Globulins is expected to grow at a CAGR of roughly 9.7% over the next five years, will reach 1960 million US$ in 2023, from 1120 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• CSL Behring
• Grifols
• Biotest
• Kedrion
• CBPO
• Emergent (Cangene)
• Kamada
• CNBG
• Hualan Bio
• Shanghai RAAS
• Sichuan Yuanda Shuyang
• ADMA Biologics

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Hepatitis B Immunoglobulins
• Rabies Immunoglobulins
• Tetanus Immunoglobulins
• Others

Market Segment by Applications, can be divided into

• Government Institutions
• Private Sector
• Other

There are 15 Chapters to deeply display the global Hyperimmune Globulins market.

Chapter 1, to describe Hyperimmune Globulins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hyperimmune Globulins, with sales, revenue, and price of Hyperimmune Globulins, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hyperimmune Globulins, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hyperimmune Globulins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Hyperimmune Globulins Introduction
1.2 Market Analysis by Type
  1.2.1 Hepatitis B Immunoglobulins
  1.2.2 Rabies Immunoglobulins
  1.2.3 Tetanus Immunoglobulins
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Government Institutions
  1.3.2 Private Sector
  1.3.3 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL Behring
  2.1.1 Business Overview
    2.1.1.1 CSL Behring Description
    2.1.1.2 CSL Behring Headquarter, Main Business and Finance Overview
  2.1.2 CSL Behring Hyperimmune Globulins Product Introduction
    2.1.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Hyperimmune Globulins Product Information
  2.1.3 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global CSL Behring Hyperimmune Globulins Market Share in 2017
2.2 Grifols
  2.2.1 Business Overview
    2.2.1.1 Grifols Description
    2.2.1.2 Grifols Headquarter, Main Business and Finance Overview
  2.2.2 Grifols Hyperimmune Globulins Product Introduction
    2.2.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Hyperimmune Globulins Product Information
  2.2.3 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Grifols Hyperimmune Globulins Market Share in 2017
2.3 Biotest
  2.3.1 Business Overview
    2.3.1.1 Biotest Description
    2.3.1.2 Biotest Headquarter, Main Business and Finance Overview
  2.3.2 Biotest Hyperimmune Globulins Product Introduction
    2.3.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Hyperimmune Globulins Product Information
  2.3.3 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Biotest Hyperimmune Globulins Market Share in 2017
2.4 Kedrion
  2.4.1 Business Overview
    2.4.1.1 Kedrion Description
    2.4.1.2 Kedrion Headquarter, Main Business and Finance Overview
  2.4.2 Kedrion Hyperimmune Globulins Product Introduction
    2.4.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Hyperimmune Globulins Product Information
  2.4.3 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Kedrion Hyperimmune Globulins Market Share in 2017
2.5 CBPO
  2.5.1 Business Overview
    2.5.1.1 CBPO Description
    2.5.1.2 CBPO Headquarter, Main Business and Finance Overview
  2.5.2 CBPO Hyperimmune Globulins Product Introduction
    2.5.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Hyperimmune Globulins Product Information
  2.5.3 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global CBPO Hyperimmune Globulins Market Share in 2017
2.6 Emergent (Cangene)
  2.6.1 Business Overview
    2.6.1.1 Emergent (Cangene) Description
    2.6.1.2 Emergent (Cangene) Headquarter, Main Business and Finance Overview
  2.6.2 Emergent (Cangene) Hyperimmune Globulins Product Introduction
    2.6.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Hyperimmune Globulins Product Information
  2.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Emergent (Cangene) Hyperimmune Globulins Market Share in 2017
2.7 Kamada
  2.7.1 Business Overview
    2.7.1.1 Kamada Description
    2.7.1.2 Kamada Headquarter, Main Business and Finance Overview
  2.7.2 Kamada Hyperimmune Globulins Product Introduction
    2.7.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Hyperimmune Globulins Product Information
  2.7.3 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Kamada Hyperimmune Globulins Market Share in 2017
2.8 CNBG
  2.8.1 Business Overview
    2.8.1.1 CNBG Description
    2.8.1.2 CNBG Headquarter, Main Business and Finance Overview
  2.8.2 CNBG Hyperimmune Globulins Product Introduction
    2.8.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Hyperimmune Globulins Product Information
  2.8.3 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global CNBG Hyperimmune Globulins Market Share in 2017
2.9 Hualan Bio
  2.9.1 Business Overview
    2.9.1.1 Hualan Bio Description
    2.9.1.2 Hualan Bio Headquarter, Main Business and Finance Overview
  2.9.2 Hualan Bio Hyperimmune Globulins Product Introduction
    2.9.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Hyperimmune Globulins Product Information
  2.9.3 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Hualan Bio Hyperimmune Globulins Market Share in 2017
2.10 Shanghai RAAS
  2.10.1 Business Overview
    2.10.1.1 Shanghai RAAS Description
    2.10.1.2 Shanghai RAAS Headquarter, Main Business and Finance Overview
  2.10.2 Shanghai RAAS Hyperimmune Globulins Product Introduction
    2.10.2.1 Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Hyperimmune Globulins Product Information
  2.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Shanghai RAAS Hyperimmune Globulins Market Share in 2017
2.11 Sichuan Yuanda Shuyang
  2.11.1 Business Overview
  2.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulins Product Introduction
  2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 ADMA Biologics
  2.12.1 Business Overview
  2.12.2 ADMA Biologics Hyperimmune Globulins Product Introduction
  2.12.3 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HYPERIMMUNE GLOBULINS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Hyperimmune Globulins Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hyperimmune Globulins Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Hyperimmune Globulins Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Hyperimmune Globulins Manufacturer Market Share in 2017
  3.4.2 Top 5 Hyperimmune Globulins Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL HYPERIMMUNE GLOBULINS MARKET ANALYSIS BY REGIONS

4.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Regions
  4.1.1 Global Hyperimmune Globulins Sales by Regions (2013-2018)
  4.1.2 Global Hyperimmune Globulins Revenue by Regions (2013-2018)
4.2 North America Hyperimmune Globulins Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Hyperimmune Globulins Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Hyperimmune Globulins Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HYPERIMMUNE GLOBULINS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
  5.1.1 North America Hyperimmune Globulins Sales by Countries (2013-2018)
  5.1.2 North America Hyperimmune Globulins Revenue by Countries (2013-2018)
  5.1.3 United States Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  5.1.4 Canada Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Hyperimmune Globulins Sales and Growth Rate (2013-2018)
5.2 North America Hyperimmune Globulins Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Hyperimmune Globulins Sales by Manufacturers (2016-2017)
  5.2.2 North America Hyperimmune Globulins Revenue by Manufacturers (2016-2017)
5.3 North America Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Hyperimmune Globulins Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Hyperimmune Globulins Revenue and Revenue Share by Type (2013-2018)
5.4 North America Hyperimmune Globulins Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Hyperimmune Globulins Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Hyperimmune Globulins Revenue and Revenue Share by Application (2013-2018)

6 EUROPE HYPERIMMUNE GLOBULINS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Countries
  6.1.1 Europe Hyperimmune Globulins Sales by Countries (2013-2018)
  6.1.2 Europe Hyperimmune Globulins Revenue by Countries (2013-2018)
  6.1.3 Germany Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  6.1.4 UK Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  6.1.5 France Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  6.1.6 Russia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  6.1.7 Italy Hyperimmune Globulins Sales and Growth Rate (2013-2018)
6.2 Europe Hyperimmune Globulins Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Hyperimmune Globulins Sales by Manufacturers (2016-2017)
  6.2.2 Europe Hyperimmune Globulins Revenue by Manufacturers (2016-2017)
6.3 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Hyperimmune Globulins Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Hyperimmune Globulins Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Hyperimmune Globulins Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Hyperimmune Globulins Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Hyperimmune Globulins Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC HYPERIMMUNE GLOBULINS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Hyperimmune Globulins Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Hyperimmune Globulins Revenue by Countries (2013-2018)
  7.1.3 China Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  7.1.4 Japan Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  7.1.5 Korea Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  7.1.6 India Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Hyperimmune Globulins Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Hyperimmune Globulins Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Hyperimmune Globulins Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Hyperimmune Globulins Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Hyperimmune Globulins Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Hyperimmune Globulins Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Hyperimmune Globulins Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Hyperimmune Globulins Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA HYPERIMMUNE GLOBULINS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Hyperimmune Globulins Sales, Revenue and Market Share by Countries
  8.1.1 South America Hyperimmune Globulins Sales by Countries (2013-2018)
  8.1.2 South America Hyperimmune Globulins Revenue by Countries (2013-2018)
  8.1.3 Brazil Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
8.2 South America Hyperimmune Globulins Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Hyperimmune Globulins Sales by Manufacturers (2016-2017)
  8.2.2 South America Hyperimmune Globulins Revenue by Manufacturers (2016-2017)
8.3 South America Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Hyperimmune Globulins Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Hyperimmune Globulins Revenue and Revenue Share by Type (2013-2018)
8.4 South America Hyperimmune Globulins Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Hyperimmune Globulins Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Hyperimmune Globulins Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA HYPERIMMUNE GLOBULINS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Hyperimmune Globulins Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Hyperimmune Globulins Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  9.1.4 UAE Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Hyperimmune Globulins Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Hyperimmune Globulins Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Hyperimmune Globulins Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Hyperimmune Globulins Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Hyperimmune Globulins Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Hyperimmune Globulins Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Hyperimmune Globulins Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Hyperimmune Globulins Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Hyperimmune Globulins Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL HYPERIMMUNE GLOBULINS MARKET SEGMENT BY TYPE

10.1 Global Hyperimmune Globulins Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Hyperimmune Globulins Sales and Market Share by Type (2013-2018)
  10.1.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2013-2018)
10.2 Hepatitis B Immunoglobulins Sales Growth and Price
  10.2.1 Global Hepatitis B Immunoglobulins Sales Growth (2013-2018)
  10.2.2 Global Hepatitis B Immunoglobulins Price (2013-2018)
10.3 Rabies Immunoglobulins Sales Growth and Price
  10.3.1 Global Rabies Immunoglobulins Sales Growth (2013-2018)
  10.3.2 Global Rabies Immunoglobulins Price (2013-2018)
10.4 Tetanus Immunoglobulins Sales Growth and Price
  10.4.1 Global Tetanus Immunoglobulins Sales Growth (2013-2018)
  10.4.2 Global Tetanus Immunoglobulins Price (2013-2018)
10.5 Others Sales Growth and Price
  10.5.1 Global Others Sales Growth (2013-2018)
  10.5.2 Global Others Price (2013-2018)

11 GLOBAL HYPERIMMUNE GLOBULINS MARKET SEGMENT BY APPLICATION

11.1 Global Hyperimmune Globulins Sales Market Share by Application (2013-2018)
11.2 Government Institutions Sales Growth (2013-2018)
11.3 Private Sector Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)

12 HYPERIMMUNE GLOBULINS MARKET FORECAST (2018-2023)

12.1 Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2018-2023)
12.2 Hyperimmune Globulins Market Forecast by Regions (2018-2023)
  12.2.1 North America Hyperimmune Globulins Market Forecast (2018-2023)
  12.2.2 Europe Hyperimmune Globulins Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Hyperimmune Globulins Market Forecast (2018-2023)
  12.2.4 South America Hyperimmune Globulins Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Hyperimmune Globulins Market Forecast (2018-2023)
12.3 Hyperimmune Globulins Market Forecast by Type (2018-2023)
  12.3.1 Global Hyperimmune Globulins Sales Forecast by Type (2018-2023)
  12.3.2 Global Hyperimmune Globulins Market Share Forecast by Type (2018-2023)
12.4 Hyperimmune Globulins Market Forecast by Application (2018-2023)
  12.4.1 Global Hyperimmune Globulins Sales Forecast by Application (2018-2023)
  12.4.2 Global Hyperimmune Globulins Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hyperimmune Globulins Picture
Table Product Specifications of Hyperimmune Globulins
Figure Global Hyperimmune Globulins CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Hyperimmune Globulins CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Hyperimmune Globulins by Types in 2017
Figure Hepatitis B Immunoglobulins Picture
Table Major Manufacturers of Hepatitis B Immunoglobulins
Figure Rabies Immunoglobulins Picture
Table Major Manufacturers of Rabies Immunoglobulins
Figure Tetanus Immunoglobulins Picture
Table Major Manufacturers of Tetanus Immunoglobulins
Figure Others Picture
Table Major Manufacturers of Others
Figure Hyperimmune Globulins Sales Market Share by Applications in 2017
Figure Government Institutions Picture
Figure Private Sector Picture
Figure Other Picture
Figure United States Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure France Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure China Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure India Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hyperimmune Globulins Revenue (Value) and Growth Rate (2013-2023)
Table CSL Behring Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Behring Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table CSL Behring Hyperimmune Globulins Product
Table CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Behring Hyperimmune Globulins Sales Market Share in 2017
Figure Global CSL Behring Hyperimmune Globulins Revenue Market Share in 2017
Table Grifols Headquarter, Established, Main Business and Finance Overview (2017)
Table Grifols Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Grifols Hyperimmune Globulins Product
Table Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Grifols Hyperimmune Globulins Sales Market Share in 2017
Figure Global Grifols Hyperimmune Globulins Revenue Market Share in 2017
Table Biotest Headquarter, Established, Main Business and Finance Overview (2017)
Table Biotest Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Biotest Hyperimmune Globulins Product
Table Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biotest Hyperimmune Globulins Sales Market Share in 2017
Figure Global Biotest Hyperimmune Globulins Revenue Market Share in 2017
Table Kedrion Headquarter, Established, Main Business and Finance Overview (2017)
Table Kedrion Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Kedrion Hyperimmune Globulins Product
Table Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kedrion Hyperimmune Globulins Sales Market Share in 2017
Figure Global Kedrion Hyperimmune Globulins Revenue Market Share in 2017
Table CBPO Headquarter, Established, Main Business and Finance Overview (2017)
Table CBPO Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table CBPO Hyperimmune Globulins Product
Table CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CBPO Hyperimmune Globulins Sales Market Share in 2017
Figure Global CBPO Hyperimmune Globulins Revenue Market Share in 2017
Table Emergent (Cangene) Headquarter, Established, Main Business and Finance Overview (2017)
Table Emergent (Cangene) Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Emergent (Cangene) Hyperimmune Globulins Product
Table Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Emergent (Cangene) Hyperimmune Globulins Sales Market Share in 2017
Figure Global Emergent (Cangene) Hyperimmune Globulins Revenue Market Share in 2017
Table Kamada Headquarter, Established, Main Business and Finance Overview (2017)
Table Kamada Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Kamada Hyperimmune Globulins Product
Table Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kamada Hyperimmune Globulins Sales Market Share in 2017
Figure Global Kamada Hyperimmune Globulins Revenue Market Share in 2017
Table CNBG Headquarter, Established, Main Business and Finance Overview (2017)
Table CNBG Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table CNBG Hyperimmune Globulins Product
Table CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CNBG Hyperimmune Globulins Sales Market Share in 2017
Figure Global CNBG Hyperimmune Globulins Revenue Market Share in 2017
Table Hualan Bio Headquarter, Established, Main Business and Finance Overview (2017)
Table Hualan Bio Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Hualan Bio Hyperimmune Globulins Product
Table Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hualan Bio Hyperimmune Globulins Sales Market Share in 2017
Figure Global Hualan Bio Hyperimmune Globulins Revenue Market Share in 2017
Table Shanghai RAAS Headquarter, Established, Main Business and Finance Overview (2017)
Table Shanghai RAAS Hyperimmune Globulins Production Bases, Sales Regions and Major Competitors
Table Shanghai RAAS Hyperimmune Globulins Product
Table Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shanghai RAAS Hyperimmune Globulins Sales Market Share in 2017
Figure Global Shanghai RAAS Hyperimmune Globulins Revenue Market Share in 2017
Table Sichuan Yuanda Shuyang
Table Sichuan Yuanda Shuyang Hyperimmune Globulins
Table ADMA Biologics
Table ADMA Biologics Hyperimmune Globulins
Table Global Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table Global Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Table Global Hyperimmune Globulins Price by Manufacturer (2016-2017)
Figure Top 3 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2017
Figure Global Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Global Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Global Hyperimmune Globulins Sales by Regions (2013-2018)
Table Global Hyperimmune Globulins Sales Market Share by Regions (2013-2018)
Table Global Hyperimmune Globulins Revenue by Regions (2013-2018)
Figure Global Hyperimmune Globulins Revenue Market Share by Regions in 2013
Figure Global Hyperimmune Globulins Revenue Market Share by Regions in 2017
Figure North America Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure North America Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Figure Europe Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Europe Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Figure South America Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure South America Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Figure North America Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table North America Hyperimmune Globulins Sales by Countries (2013-2018)
Table North America Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure North America Hyperimmune Globulins Sales Market Share by Countries in 2013
Figure North America Hyperimmune Globulins Sales Market Share by Countries in 2017
Table North America Hyperimmune Globulins Revenue by Countries (2013-2018)
Table North America Hyperimmune Globulins Revenue Market Share by Countries (2013-2018)
Figure North America Hyperimmune Globulins Revenue Market Share by Countries in 2013
Figure North America Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure United States Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Canada Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Mexico Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Table North America Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure North America Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure North America Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table North America Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure North America Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure North America Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Table North America Hyperimmune Globulins Sales by Type (2013-2018)
Table North America Hyperimmune Globulins Sales Share by Type (2013-2018)
Table North America Hyperimmune Globulins Revenue by Type (2013-2018)
Table North America Hyperimmune Globulins Revenue Share by Type (2013-2018)
Table North America Hyperimmune Globulins Sales by Application (2013-2018)
Table North America Hyperimmune Globulins Sales Share by Application (2013-2018)
Table North America Hyperimmune Globulins Revenue by Application (2013-2018)
Table North America Hyperimmune Globulins Revenue Share by Application (2013-2018)
Figure Europe Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Europe Hyperimmune Globulins Sales by Countries (2013-2018)
Table Europe Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Table Europe Hyperimmune Globulins Revenue by Countries (2013-2018)
Figure Europe Hyperimmune Globulins Revenue Market Share by Countries in 2016
Figure Europe Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Germany Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure UK Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure France Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Russia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Italy Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Table Europe Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure Europe Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure Europe Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table Europe Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure Europe Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure Europe Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Table Europe Hyperimmune Globulins Sales by Type (2013-2018)
Table Europe Hyperimmune Globulins Sales Share by Type (2013-2018)
Table Europe Hyperimmune Globulins Revenue by Type (2013-2018)
Table Europe Hyperimmune Globulins Revenue Share by Type (2013-2018)
Table Europe Hyperimmune Globulins Sales by Application (2013-2018)
Table Europe Hyperimmune Globulins Sales Share by Application (2013-2018)
Table Europe Hyperimmune Globulins Revenue by Application (2013-2018)
Table Europe Hyperimmune Globulins Revenue Share by Application (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales by Countries (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Sales Market Share by Countries 2017
Table Asia-Pacific Hyperimmune Globulins Revenue by Countries (2013-2018)
Figure Asia-Pacific Hyperimmune Globulins Revenue Market Share by Countries 2017
Figure China Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Japan Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Korea Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure India Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Southeast Asia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Hyperimmune Globulins Sales by Type (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales Share by Type (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Revenue by Type (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Revenue Share by Type (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales by Application (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Sales Share by Application (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Revenue by Application (2013-2018)
Table Asia-Pacific Hyperimmune Globulins Revenue Share by Application (2013-2018)
Figure South America Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table South America Hyperimmune Globulins Sales by Countries (2013-2018)
Table South America Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure South America Hyperimmune Globulins Sales Market Share by Countries in 2017
Table South America Hyperimmune Globulins Revenue by Countries (2013-2018)
Table South America Hyperimmune Globulins Revenue Market Share by Countries (2013-2018)
Figure South America Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Brazil Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Argentina Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Colombia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Table South America Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure South America Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure South America Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table South America Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure South America Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure South America Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Table South America Hyperimmune Globulins Sales by Type (2013-2018)
Table South America Hyperimmune Globulins Sales Share by Type (2013-2018)
Table South America Hyperimmune Globulins Revenue by Type (2013-2018)
Table South America Hyperimmune Globulins Revenue Share by Type (2013-2018)
Table South America Hyperimmune Globulins Sales by Application (2013-2018)
Table South America Hyperimmune Globulins Sales Share by Application (2013-2018)
Table South America Hyperimmune Globulins Revenue by Application (2013-2018)
Table South America Hyperimmune Globulins Revenue Share by Application (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales by Countries (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Sales Market Share by Countries in 2017
Table Middle East and Africa Hyperimmune Globulins Revenue by Countries (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries in 2013
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure UAE Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Egypt Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure Nigeria Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Figure South Africa Hyperimmune Globulins Sales and Growth Rate (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Hyperimmune Globulins Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Hyperimmune Globulins Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Hyperimmune Globulins Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Hyperimmune Globulins Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Hyperimmune Globulins Sales by Type (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales Share by Type (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Revenue by Type (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Revenue Share by Type (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales by Application (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Sales Share by Application (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Revenue by Application (2013-2018)
Table Middle East and Africa Hyperimmune Globulins Revenue Share by Application (2013-2018)
Table Global Hyperimmune Globulins Sales by Type (2013-2018)
Table Global Hyperimmune Globulins Sales Share by Type (2013-2018)
Table Global Hyperimmune Globulins Revenue by Type (2013-2018)
Table Global Hyperimmune Globulins Revenue Share by Type (2013-2018)
Figure Global Hepatitis B Immunoglobulins Sales Growth (2013-2018)
Figure Global Hepatitis B Immunoglobulins Price (2013-2018)
Figure Global Rabies Immunoglobulins Sales Growth (2013-2018)
Figure Global Rabies Immunoglobulins Price (2013-2018)
Figure Global Tetanus Immunoglobulins Sales Growth (2013-2018)
Figure Global Tetanus Immunoglobulins Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Hyperimmune Globulins Sales by Application (2013-2018)
Table Global Hyperimmune Globulins Sales Share by Application (2013-2018)
Figure Global Government Institutions Sales Growth (2013-2018)
Figure Global Private Sector Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Hyperimmune Globulins Sales, Revenue and Growth Rate (2018-2023)
Table Global Hyperimmune Globulins Sales Forecast by Regions (2018-2023)
Table Global Hyperimmune Globulins Market Share Forecast by Regions (2018-2023)
Figure North America Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure Europe Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure Asia-Pacific Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure South America Sales Hyperimmune Globulins Market Forecast (2018-2023)
Figure Middle East and Africa Sales Hyperimmune Globulins Market Forecast (2018-2023)
Table Global Hyperimmune Globulins Sales Forecast by Type (2018-2023)
Table Global Hyperimmune Globulins Market Share Forecast by Type (2018-2023)
Table Global Hyperimmune Globulins Sales Forecast by Application (2018-2023)
Table Global Hyperimmune Globulins Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List